304 related articles for article (PubMed ID: 29103990)
1. A Call to Arms: Quest for a Cryptococcal Vaccine.
Caballero Van Dyke MC; Wormley FL
Trends Microbiol; 2018 May; 26(5):436-446. PubMed ID: 29103990
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
3. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
4. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
5. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and prospects for a vaccine to prevent cryptococcosis.
Casadevall A; Pirofski LA
Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
Hester MM; Lee CK; Abraham A; Khoshkenar P; Ostroff GR; Levitz SM; Specht CA
Vaccine; 2020 Jan; 38(3):620-626. PubMed ID: 31699504
[TBL] [Abstract][Full Text] [Related]
8. Methodology for Anti-Cryptococcal Vaccine Development.
Chaturvedi AK; Wormley FL
Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Strategies for Cryptococcus neoformans.
Brauer VS; Querobino SM; Matos GS; Dasilva D; Del Poeta M
Methods Mol Biol; 2024; 2775():411-422. PubMed ID: 38758334
[TBL] [Abstract][Full Text] [Related]
10.
Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
[No Abstract] [Full Text] [Related]
11. Innate host defenses against Cryptococcus neoformans.
Hole C; Wormley FL
J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
[TBL] [Abstract][Full Text] [Related]
13. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
Datta K; Pirofski LA
FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of antigenic fractions in mouse models of cryptococcosis.
Mansour MK; Yauch LE; Rottman JB; Levitz SM
Infect Immun; 2004 Mar; 72(3):1746-54. PubMed ID: 14977983
[TBL] [Abstract][Full Text] [Related]
15. Design of a cryptococcus neoformans vaccine by subtractive proteomics combined with immunoinformatics.
Zhu F; Zhou Z; Ma S; Xu Y; Tan C; Yang H; Zhang P; Qin R; Luo Y; Pan P; Chen J
Int Immunopharmacol; 2024 Jun; 135():112242. PubMed ID: 38772296
[TBL] [Abstract][Full Text] [Related]
16. Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Leopold Wager CM; Wormley FL
PLoS Pathog; 2015 Jun; 11(6):e1004843. PubMed ID: 26087178
[No Abstract] [Full Text] [Related]
17. Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines.
Specht CA; Lam WC; Hester MM; Lourenco D; Levitz SM; Lodge JK; Upadhya R
Methods Mol Biol; 2024; 2775():393-410. PubMed ID: 38758333
[TBL] [Abstract][Full Text] [Related]
18. Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB/c mice.
Khan AA; Jabeen M; Chauhan A; Owais M
J Drug Target; 2012 Jun; 20(5):453-66. PubMed ID: 22553959
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
Hansakon A; Ngamskulrungroj P; Angkasekwinai P
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
